Low rates of major PICC-associated complications attributed in-part to the novel BioFlo catheter material
Data to be presented at AngioDynamics-sponsored symposium at the annual scientific meeting of the Association for Vascular Access
ALBANY, N.Y., Sept. 14, 2017 (GLOBE NEWSWIRE) —  AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today the publication of a nurse-led, peripherally inserted central catheter (PICC) study in the July 4, 2017 edition of CMAJ Open. The research concluded that low rates of major PICC-associated complications are attributed in-part to the novel BioFlo catheter material, as well as a nurse-led expert insertion team, standardised care and maintenance protocols, high insertion volumes and continuous quality improvement initiatives. CMAJ Open is an online medical and health research journal of the Canadian Medical Association…
AngioDynamics Inc. is a leading provider of innovative, minimally invasive medical devices used by professional healthcare providers for vascular access, surgery, peripheral vascular disease and oncology. AngioDynamics’ diverse product lines include market-leading ablation systems, fluid management systems, vascular access products, angiographic products and accessories, drainage products, thrombolytic products and venous products.  Read study here
FloMedical offers Peripherally Inserted Central Catheter Program in vascular access devices for clinicians, nurses, PICC teams and other medical professionals. Ongoing seminars, training days and demonstrations are paramount in our quest to provide solutions to you, as medical professionals. Find out more about Peripherally Inserted Central Catheter Program.